Acalabrutinib (Calquence; AstraZeneca) demonstrated a more modest ORR of 40% in a smaller 25-patient cohort, with median progression-free survival (PFS) of 3.2 months. While less robust than ...
For generations, wise aunties and grandmothers have advised that the quickest path to the heart is through the stomach. Our ...
The Managed Care Resource Alliance (MCRA) announces the appointment of Desiree Vuocolo as Director of Programs and ...
Cutting-edge cell testing solution analyzes cell State of Health 19x faster than traditional cyclers. We’ve got a ...
aDepartment of Hematology, Centre for Leading Medicine and Advanced Technologies of Institute of Health and Medicine, The First Affiliated Hospital of University of Science and Technology of China, ...
One of the persistent illusions of life is linearity, the idea that tomorrow will be just like yesterday. While this often seems accurate, it lulls us into complacency, unprepared when sudden ...
Diffuse large B-cell lymphoma is a common type of non-Hodgkin’s lymphoma that also has a high rate of relapse. Common signs of a relapse include lymph node swelling, as well as the development of “B ...
Chairman and CEO Robert Davis emphasized the company's portfolio transformation, highlighting, "In 2025, our business benefited from successful new product launches, the advancement of important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results